A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA ...

GLP-1 RA use and misuse was prevalent among people with eating disorders and commonly accompanied by psychiatric and medical ...

The prevalence of GLP-1 receptor agonists for weight management in Great Britain highlights public interest and concerns over ...

A renowned obesity and metabolism specialist says regulators around the world are struggling to keep pace with soaring demand ...

Online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors frequently do not require clinician interaction, according to a research lette ...

Two drugs now generate almost two-thirds of the pharmaceutical giant's revenue.

Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

The eating plan has become a favorite among several high-profile government officials, but it’s about much more than fermented cabbage.

These risks are significantly exacerbated if a Type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, research assistant professor in the Department of Pharmacy Practice in the UB ...

In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase ...

In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ...